Vetsys Pharmaceutical
Vetsys Pharmaceutical
Established in 2005, Zhengzhou Vetsys Pharmaceutical Co., Ltd. (Vetsys) is a leading manufacturer in the animal pharmaceutical industry with a registered capital of 30 million RMB. Our facility includes specialized workshops for producing a wide range of products, including powders & premixes, injections, powder injections, oral solutions, tablets, granules, herbal drug extracts, and disinfectants.
Vetsys operates in compliance with strict Good Manufacturing Practices (GMP) to ensure that all products meet the highest quality standards. Over the years, the company has grown to become one of the top animal pharmaceutical producers in China, achieving annual sales of over USD 20 million in the domestic market by 2015. This trajectory is built on a foundation of reliability and deep industry expertise.
The demand for high-quality Injectable Suspensions is surging worldwide. As the global population grows, the demand for animal protein rises, necessitating advanced veterinary healthcare. Injectable suspensions are preferred in commercial livestock farming for their sustained-release properties, ensuring effective therapeutic levels of antibiotics like Amoxicillin or Ceftiofur over extended periods with fewer interventions.
Modern trends are shifting toward "Precision Veterinary Medicine." This involves developing formulations that offer higher bioavailability and lower toxicity. We see a significant move towards Long-Acting (LA) suspensions that reduce animal stress and labor costs. Digital tracking of pharmaceutical efficacy and the integration of green chemistry in manufacturing are also becoming standard requirements for top-tier suppliers.
Global procurement agents are no longer just looking for the lowest price; they are seeking stability and transparency. Large-scale agricultural enterprises in South America, the EU, and Southeast Asia require manufacturers who can guarantee batch-to-batch consistency and comply with rigorous international safety standards. Vetsys meets these needs through our integrated supply chain and rigorous QC protocols.
Our injectable suspensions are engineered for diverse environments:
Partnering with a leading Chinese manufacturer like Vetsys Pharmaceutical offers distinct strategic advantages:
Vetsys distinguishes itself from competitors by placing a strong emphasis on technological development and continuous innovation. We have established an independent research institute equipped with five specialized laboratories and a team of world-class scientists. This enables us to quickly adapt to market demands and produce cutting-edge solutions for animal health.
Our commitment to research ensures that Vetsys remains at the forefront of the industry, continuously enhancing our product offerings and contributing to advancements in animal healthcare. By focusing on molecular stability and particle size optimization in our suspensions, we ensure maximum efficacy for the end-user.
Mold Injection
Welding
Assembly
Packaging
Injection Molding
Blow Molding
Extrusion Molding
Cotton Swab Processing
Drying
Assembly
Professional Packing
Quality is the cornerstone of our operations. Vetsys has developed a comprehensive quality management system to oversee every aspect of production. We adhere to rigorous GMP standards, ensuring that all products are manufactured under optimal conditions and undergo extensive quality control checks before reaching the market. We believe that excellence in product quality is essential to long-term growth and sustainability for both the company and the animal health industry.
As part of our long-term vision, Vetsys is committed to sustainability. We continue to invest in green technologies and environmentally friendly practices to minimize our operational impact. Our products are not only designed for efficacy but also to promote the overall well-being of both animals and the environment. We are actively exploring international expansion, aiming to bring high-quality, innovative animal health solutions to global markets.
At Vetsys, we are driven by our mission to improve animal health through continuous innovation, world-class quality, and sustainable practices. We remain committed to creating value for our customers, employees, and society as we continue to shape the future of animal healthcare. Our strategy includes partnerships, research collaborations, and expanding our manufacturing capabilities to meet the increasing demand for safe and effective animal drugs worldwide.
